| __timestamp | Takeda Pharmaceutical Company Limited | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 1256834000000 | 1162636000 |
| Thursday, January 1, 2015 | 1271973000000 | 1396725000 |
| Friday, January 1, 2016 | 1173296000000 | 1526100000 |
| Sunday, January 1, 2017 | 1274610000000 | 1619600000 |
| Monday, January 1, 2018 | 1437534000000 | 1429100000 |
| Tuesday, January 1, 2019 | 2201424000000 | 1331200000 |
| Wednesday, January 1, 2020 | 2203504000000 | 1375200000 |
| Friday, January 1, 2021 | 2462160000000 | 1563000000 |
| Saturday, January 1, 2022 | 2783406000000 | 1789600000 |
| Sunday, January 1, 2023 | 2832257000000 | 2070000000 |
| Monday, January 1, 2024 | 2832257000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, understanding the financial health of industry leaders is crucial. Takeda Pharmaceutical Company Limited, a Japanese titan, and United Therapeutics Corporation, a pioneering American biotech firm, offer a fascinating study in contrasts. Over the past decade, Takeda's gross profit has surged by approximately 125%, peaking in 2023. This growth reflects its strategic acquisitions and robust product pipeline. In contrast, United Therapeutics has seen a steady increase of around 78% in gross profit, highlighting its focus on niche markets and innovative therapies.
While Takeda's profits dwarf those of United Therapeutics, the latter's consistent growth underscores its resilience and strategic focus. Notably, data for 2024 is incomplete, suggesting potential shifts in the competitive landscape. As these companies navigate the future, their financial trajectories will be pivotal in shaping the global pharmaceutical industry.
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Zoetis Inc. vs United Therapeutics Corporation
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Arrowhead Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends
Gross Profit Analysis: Comparing United Therapeutics Corporation and Amneal Pharmaceuticals, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Arrowhead Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? United Therapeutics Corporation or Veracyte, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs MiMedx Group, Inc.
Key Insights on Gross Profit: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc.